180 related articles for article (PubMed ID: 23448506)
1. Emergent biological properties of arrestin pathway-selective biased agonism.
Appleton KM; Luttrell LM
J Recept Signal Transduct Res; 2013 Jun; 33(3):153-61. PubMed ID: 23448506
[TBL] [Abstract][Full Text] [Related]
2. Arrestin pathways as drug targets.
Luttrell LM
Prog Mol Biol Transl Sci; 2013; 118():469-97. PubMed ID: 23764065
[TBL] [Abstract][Full Text] [Related]
3. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
4. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
5. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
6. Refining efficacy: exploiting functional selectivity for drug discovery.
Gesty-Palmer D; Luttrell LM
Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
[TBL] [Abstract][Full Text] [Related]
7. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
Luttrell LM; Maudsley S; Bohn LM
Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
[TBL] [Abstract][Full Text] [Related]
8. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
9. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
[TBL] [Abstract][Full Text] [Related]
10. 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass?
Gesty-Palmer D; Luttrell LM
Br J Pharmacol; 2011 Sep; 164(1):59-67. PubMed ID: 21506957
[TBL] [Abstract][Full Text] [Related]
11. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
12. Emerging structural insights into biased GPCR signaling.
Shukla AK; Singh G; Ghosh E
Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
[TBL] [Abstract][Full Text] [Related]
13. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
Stott LA; Hall DA; Holliday ND
Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
[TBL] [Abstract][Full Text] [Related]
14. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
15. Understanding the GPCR biased signaling through G protein and arrestin complex structures.
Zhou XE; Melcher K; Xu HE
Curr Opin Struct Biol; 2017 Aug; 45():150-159. PubMed ID: 28558341
[TBL] [Abstract][Full Text] [Related]
16. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.
Luttrell LM
Mol Endocrinol; 2014 Mar; 28(3):281-94. PubMed ID: 24433041
[TBL] [Abstract][Full Text] [Related]
17. Delineation of a conserved arrestin-biased signaling repertoire in vivo.
Maudsley S; Martin B; Gesty-Palmer D; Cheung H; Johnson C; Patel S; Becker KG; Wood WH; Zhang Y; Lehrmann E; Luttrell LM
Mol Pharmacol; 2015 Apr; 87(4):706-17. PubMed ID: 25637603
[TBL] [Abstract][Full Text] [Related]
18. When simple agonism is not enough: emerging modalities of GPCR ligands.
Smith NJ; Bennett KA; Milligan G
Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
[TBL] [Abstract][Full Text] [Related]
19. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment.
Oakley RH; Hudson CC; Sjaastad MD; Loomis CR
Methods Enzymol; 2006; 414():50-63. PubMed ID: 17110186
[TBL] [Abstract][Full Text] [Related]
20. Delineating biased ligand efficacy at 7TM receptors from an experimental perspective.
Galandrin S; Onfroy L; Poirot MC; Sénard JM; Galés C
Int J Biochem Cell Biol; 2016 Aug; 77(Pt B):251-63. PubMed ID: 27107932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
